abstract |
(57) [Summary]nThe present invention relates to novel 2,3-disubstituted 4 (3H) -quinazolinone compounds of formula (I), and pharmaceutically acceptable salts thereof, and pharmaceutical compositions for treating neurodegeneration and CNS-trauma-related conditions And methods. |